VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

Pauline Lemmens  1     João Sabino  1     Edouard Louis  2     Wouter Van Moerkercke  3     Lieven Pouillon  4     Michaël Somers  5     Harald Peeters  6     Stijn Dr. Vanden Branden  7     Julie Busschaert     Filip Baert     Anneline Cremer     Philippe Potvin     Sophie Dewit     Arnaud Colard     Jo Swinnen     Guy Lambrecht     Christophe Claessens     Barbara Willandt     Pieter Dewint     Evi    
1 University Hospital Leuven, Leuven, Belgium
2 CHU Liège and Liège University, Liège, Belgium
3 AZ Groeninge, Kortrijk, Belgium
4 Imelda Hospital, Bonheiden, Belgium
5 University Hospital Antwerp, Antwerp, Belgium
6 University Hospital Gent, Gent, Belgium
7 Onze Lieve Vrouw Hospital, Aalst, Belg

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing